Cambridge Innovation Institute Acquires Neurotech Reports

Neurotone AI Acquires Amptify

December 4, 2024

Healthcare Services

Neurotone AI, the creator of Lace AI Pro, entered into a definitive agreement to acquire Amptify, a digital hearing healthcare platform developed at Washington University in St. Louis School of Medicine. The deal is expected to close by the end of 2024 and will integrate Amptify’s content—particularly cochlear implant rehabilitation and communication strategies—into Lace AI Pro to expand offerings for audiology practices.

Nihon Kohden Acquires 71.4% Stake in Ad‑Tech from ARCHIMED

November 26, 2024

Medical Devices

Nihon Kohden has acquired a 71.4% stake in NeuroAdvanced Corp., the parent of Ad‑Tech Medical Instrument Corporation, from ARCHIMED’s MED II fund, with ARCHIMED retaining a 28.6% minority stake and entering a joint venture with Nihon Kohden. The deal brings together Nihon Kohden’s EEG and monitoring platform with Ad‑Tech’s intracranial neuroelectrodes to strengthen epilepsy diagnostics and expand Ad‑Tech’s global reach across North America, Europe and Asia.

Lantheus Holdings Acquires Cerveau Technologies

February 6, 2023

Pharmaceuticals

Lantheus Holdings, Inc. acquired Knoxville-based Cerveau Technologies, Inc., gaining MK-6240, a clinical-stage F-18 PET imaging agent that targets Tau tangles in Alzheimer's disease. The stock purchase includes upfront and potential milestone payments plus royalty obligations and will expand Lantheus' radiopharmaceutical diagnostic imaging pipeline and research collaborations.

Novotech Acquires US-based Regulatory Consulting Firm CBR International

January 9, 2023

Healthcare Services

Novotech, an Asia-Pacific–focused clinical research organization (CRO), has acquired US-based regulatory and drug development consultancy CBR International. The acquisition strengthens Novotech's US FDA regulatory, scientific and clinical development capabilities to better support biotech and pharma clients across the US, Europe and Asia-Pacific.

BioNTech Acquires Neon Therapeutics

January 16, 2020

Biotechnology

BioNTech SE will acquire Neon Therapeutics, Inc. in an all-stock transaction valued at approximately $67.0 million. Neon, a Cambridge-based developer of neoantigen-targeted T cell therapies, will become a wholly owned subsidiary of BioNTech to expand BioNTech’s T cell therapy capabilities and U.S. presence.

Cambridge Innovation Institute Acquires Trends Equity (AI World Conference & AI Trends)

April 18, 2018

Media & Entertainment

Cambridge Innovation Institute (CII) acquired Westborough, Massachusetts–based Trends Equity, Inc., including the AI World Conference & Expo and the AI Trends publication. The deal expands CII’s events and publishing portfolio into enterprise AI and enables rapid vertical expansion into markets such as healthcare, finance and manufacturing.